does medicaid pay for semaglutide Louisiana lawmakers are considering a bill that would expand access to GLP-1 drugs obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Wegovy® access expanded for Medicare

A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity The FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese

When the body is overwhelmed or unbalanced, this translates to its largest organ, which is the skin

Using in vivo fiber photometry, we discovered distinct pharmacologic and physiologic roles for the incretin hormones glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1)

Slow gastric emptying Reduce hunger Improve blood sugar control Support fat loss, especially visceral fat These medications have transformed treatment for obesity, insulin resistance, prediabetes, and metabolic syndrome, but one major obstacle remains, the cost

Qiu Y, Yang X, Wang L, Gao K, Jiang Z

Slower movement of food through the small intestine allows bacteria to linger and multiply